PHAT
Phathom Pharmaceuticals Inc
NASDAQ: PHAT · HEALTHCARE · BIOTECHNOLOGY
$11.20
-4.92% today
Updated 2026-04-30
Market cap
$935.69M
P/E ratio
—
P/S ratio
5.34x
EPS (TTM)
$-3.03
Dividend yield
—
52W range
$2 – $18
Volume
1.2M
Phathom Pharmaceuticals Inc (PHAT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-126.40%
Operating margin
-10.30%
ROE
-3,489.00%
ROA
-31.40%
Debt/equity
-0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-1.29M | — | — | — |
| 2019 | $0.00 | $-209.74M | — | — | — |
| 2020 | $0.00 | $-129.07M | — | — | — |
| 2021 | $0.00 | $-143.88M | — | — | — |
| 2022 | $0.00 | $-197.72M | — | — | — |
| 2023 | $682000.00 | $-201.59M | 75.51% | -24,532.55% | -29,558.94% |
| 2024 | $55.25M | $-334.33M | 85.57% | -502.18% | -605.09% |
| 2025 | $175.11M | $-221.25M | 87.09% | -91.36% | -126.35% |